Evidence map›Paper›PMID 35501895›Full record

ArticleHealth research policy and systems2022

Collective health research assessment: developing a tool to measure the impact of multistakeholder research initiatives.

Anna-Aurora Kork, Carla Antonini, Nicolás García-Torea, Mercedes Luque-Vílchez, Ericka Costa, Juliette Senn, Carlos Larrinaga, Deborah Bertorello, Giampaolo Brichetto, Paola Zaratin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Health research policy and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Anna-Aurora KorkFaculty of Social Sciences, Tampere University, Tampere, Finland. anna.kork@tuni.fi.ORCID http://orcid.org/0000-0002-2658-0918
Carla AntoniniDepartment of Accounting, Universidad Autónoma de Madrid, Madrid, Spain.
Nicolás García-ToreaDepartment of Economy and Business Administration, Universidad de Burgos, Burgos, Spain.
Mercedes Luque-VílchezDepartment of Agriculture Economy, Finance and Accounting, Universidad de Córdoba, Córdoba, Spain.
Ericka CostaDepartment of Economic and Management, University of Trento, Trento, Italy.
Juliette SennMontpellier Business School, Montpellier, France.
Carlos LarrinagaDepartment of Economy and Business Administration, Universidad de Burgos, Burgos, Spain.
Deborah BertorelloFISM-Italian Multiple Sclerosis Society Foundation, Genoa, Italy.
Giampaolo BrichettoFISM-Italian Multiple Sclerosis Society Foundation, Genoa, Italy.
Paola ZaratinFISM-Italian Multiple Sclerosis Society Foundation, Genoa, Italy.
Michele AndreausDepartment of Economic and Management, University of Trento, Trento, Italy.
Associazione Italiana Sclerosi Multipla · ITUniversidad de Burgos · ESUniversity of Trento · ITMontpellier Business School · FRTampere University · FIUniversidad Autónoma de Madrid · ESUniversity of Córdoba · ES

Funding

Horizon 2020 787570
6 · The paper itself

Abstract

backgroundThe need to more collaboratively measure the impact of health research and to do so from multidimensional perspectives has been acknowledged. A scorecard was developed as part of the Collective Research Impact Framework (CRIF), to engage stakeholders in the assessment of the impacts of health research and innovations. The purpose of this study was to describe the developmental process of the MULTI-ACT Master Scorecard (MSC) and how it can be used as a workable tool for collectively assessing future responsible research and innovation measures.

methodsAn extensive review of the health research impact literature and of multistakeholder initiatives resulted in a database of 1556 impact indicators. The MSC was then cocreated by engaging key stakeholders and conducting semi-structured interviews of experts in the field.

resultsThe MSC consists of five accountability dimensions: excellence, efficacy, economic, social and patient-reported outcomes. The tool contains 125 potential indicators, classified into 53 impact measurement aspects that are considered the most relevant topics for multistakeholder research and innovation initiatives when assessing their impact on the basis of their mission and their stakeholders' interests. The scorecard allows the strategic management of multistakeholder research initiatives to demonstrate their impact on people and society. The value of the tool is that it is comprehensive, customizable and easy to use.

conclusionsThe MSC is an example of how the views of society can be taken into account when research impacts are assessed in a more sustainable and balanced way. The engagement of patients and other stakeholders is an integral part of the CRIF, facilitating collaborative decision-making in the design of policies and research agendas. In policy making, the collective approach allows the evaluation perspective to be extended to the needs of society and towards responsible research and innovation. Multidimensionality makes research and innovations more responsive to systemic challenges, and developing more equitable and sustainable health services.

Indexed as

Health Services ResearchPolicy MakingHumansMeasurementMultistakeholderPatient-reported dimensionPaybackResearch impactResponsible research and innovationScorecard

Identifiers

PMID35501895
PMCPMC9063051
OpenAlexW4225262903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.